Search

everythinglearnresearchcommunity

for

Search:↓

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Radiesse is a versatile facial injectable used for cosmetic improvements and long-term collagen production, with careful dosing needed to prevent complications.

Stereotactic body radiation therapy and radiosurgery are advanced, precise treatments that target tumors while protecting healthy tissue.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Resveratrol shows health benefits but faces challenges in effectiveness and regulation.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

RCS-01 cell therapy is safe and improves skin gene expression.

Ritlecitinib works well and is safe for treating alopecia areata.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

Early diagnosis with trichoscopy can improve management and quality of life for CCCA patients.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Combining PRS with TAFR is promising for treating complex fistulas, with most patients achieving long-term healing.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Fractional radiofrequency effectively and safely improves rosacea symptoms.

Reflectance confocal microscopy is useful for diagnosing and monitoring skin diseases, but it has limitations and requires expertise for correct use.